Zentalis Pharmaceuticals Cash Flow Statement 2019-2024 | ZNTL

Fifteen years of historical annual cash flow statements for Zentalis Pharmaceuticals (ZNTL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-292.31$-237.11$-166.09$-118.55$-46.38
$-11.77$-2.30$1.45$0.72$0.11
$90.39$62.41$-6.06$23.16$0.62
$78.62$60.11$-4.61$23.88$0.73
$0$0$0$0$0.78
$0$0$0$0$0
$0$0$0$0$0
$-5.06$-2.28$2.64$-6.46$-1.39
$5.86$13.25$16.61$7.84$6.51
$-207.82$-163.75$-154.09$-86.83$-39.14
$-0.58$-2.55$-6.11$-0.76$-0.35
$0$0$0$0$0
$0$0$0$0$0
$-43.88$-111.63$2.31$-284.07$0
$0$0$0$0$0
$-43.88$-111.63$2.31$-284.07$0
$0$0$-14.32$0$0
$-44.46$-114.18$-18.12$-284.83$-0.35
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$237$261$180$328$0
$237$261$180$342$81.88
$0$0$0$0$0
$0$0$-1.15$18.42$-0.05
$237$261$179$360$81.83
$-14.98$-16.89$6.31$-11.22$42.34
$54.82$46.84$35.74$23.15$0.62
$0$0$0$0$0